Pacira BioSciences (PCRX) – Press Releases
-
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
-
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
-
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
-
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
-
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
-
G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
-
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Pacira Appoints Frank D. Lee as Chief Executive Officer
-
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
-
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
-
Pacira BioSciences Reports Third Quarter 2023 Financial Results
-
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
-
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
-
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
-
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
-
Pacira BioSciences Announces Leadership Succession Plan
-
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
-
Pacira BioSciences Reports Second Quarter 2023 Financial Results
-
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
-
Pacira BioSciences Reports First Quarter 2023 Financial Results
-
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
-
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
-
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
-
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
-
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
-
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
-
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
-
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
-
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
-
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
-
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
-
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
-
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
-
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
-
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
-
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
-
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
-
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
-
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
-
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
-
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
Back to PCRX Stock Lookup
